Brief history of the Endowment
A major priority at the Starzl Transplantation Institute is solidifying support for our research programs, which are at the forefront of innovation in all aspects of transplantation science. The University of Pittsburgh, where the Starzl Transplantation Institute is housed, ranked fourth in Surgery in the 2022 U.S. News and World Report “Best Global Universities” rankings. Our transplant program has pioneered liver transplantation, development of immunosuppressives, and conducts more live liver transplants than any other program in the United States. Our University’s research programs rank eighth in number of dollars funded by the National Institutes of Health (NIH), and 13th in number of NIH grants awarded in 2021. Continuing support for this world-class program is vital to its continued success.
The Thomas E. Starzl Legacy Endowment, established in 2006, creates a perpetual funding source to support our research and keep the Institute at the cutting edge of transplant research efforts.
By supporting our efforts, you allow us to carry on our tradition of excellence in medical research. Your generosity is the key to our success – thank you.
Endowment impact/important research projects
Past groundbreaking projects funded by the Thomas E. Starzl Legacy Endowment include:
- Tolerance induction
- New immunosuppressive medications
- Liver tumor therapy
- Novel tests for the prediction and diagnosis of rejection